1 / 20

Empowering Progress: European Advocacy for Microbicides

Join us in advancing microbicide technologies and strategies at the Global Campaign Strategy Meeting in Europe. Explore the current state, challenges, and funding needs of microbicides research. Engage in advocacy, coordination, and collaboration to drive regulatory approval and funding allocation. Discover how European partners can contribute to advancing microbicides on a global scale.

nelly
Download Presentation

Empowering Progress: European Advocacy for Microbicides

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Campaign Europe: Making it better, stronger and more strategic Rebekah Webb, Coordinator Global Campaign for Microbicides

  2. Welcome to PATH Ferney • Program for Appropriate Technology in Health (PATH) • PATH’s mission is to improve the health of people around the world by advancing technologies, strengthening systems, and encouraging healthy behaviour • Administrative home for the Global Campaign

  3. Strategy Meeting Goals: • To improve GCE advocacy and coordination • To share approaches, experiences and best practices • To discuss and strategise the future direction for GCE

  4. Warm-Up Exercise What do you want to have achieved with respect to microbicides in 2 years’ time? What would make you smile?   

  5. Coordinating Advocating Supporting Mobilising Awareness raising/promoting Collaborating Alliance New effort Focal point Reminding people Motivating Sustaining Last year we asked: What is GC Europe? “Not really a campaign – more a policy + advocacy collaboration”

  6. Overview of Microbicides State of Play  • Huge progress in last 5 years • Multiple products in trials – two years from now, first efficacy results for 3 different strategies • Promising new strategies for design/delivery • Funding is increasing steadily • International recognition of the potential role for microbicides

  7. Overview  • Despite the hype, still a long way to go • Current trials may not show effectiveness • Estimated $280 million needed over 10 years to get a vaginal microbicide • Rectal will cost about two-thirds of this amount • Other research needs must be funded too (e.g. microbicides for positive women) • The field is not prepared yet for the next stage

  8. QUIZ Q - Which European country is the largest donor to microbicides research? A – the United Kingdom ($14.5 million annually)

  9. QUIZ Q - Which European country leads the world in terms of contribution to microbicides as a share of GDP? A – Ireland and the Netherlands

  10. Four Strategies

  11. Trials • Six products in Phase 3/2B (vaginal endpoint) • Total of 14 products in clinical trials – some with more than one formulation • Over 20 others behind that (no funding to push them on or not good enough to take on?) • Rectal trials beginning

  12. 5 Products Furthest Along

  13. Priorities for the field • Broaden the pipeline • Ensure success in clinical research • Improve regulatory landscape • Allocate sufficient funding • Manage resources well • Create dedicated research programs

  14. What is needed • Contract mechanisms between governments and small biotechs to boost early research • Increased private sector investment • EMEA - clear standards for evidence and data required

  15. Regulatory issues • Tightrope between approving too quickly or too slowly • How can regulatory approaches anticipate and review data and still get products to people quickly

  16. EU Member States Donors = NORWAYSWEDEN DENMARK N’LANDS IRELANDUK Targets = BELGIUM GERMANYFRANCE ITALY

  17. Other pan-European models • EATG • IPPF-EN • IAVI European partners • AIDS Action Europe • EuroNGOs • European Women’s Lobby

  18. Should we join other networks? • Financial constraints on what we can put in (no revenue from partners) • Need to get microbicides onto their agendas – easier at the table • Many of our partners are members of these networks • Will our partners feel that they don’t have to raise microbicides because we are now there?

  19. European Working Group • Consisting of all the partners in Europe • Selected smaller group - elected or self-selecting? • Responsibilities: fundraising, strategy, advice, material creation and support to secretariat staff • TOR

  20. Projects pending • Finnish Presidency Meeting (Nordpol, IPPF-EN?) • European tour of the exhibit (European Commission, EP, Interact, Cairde, AIDS Fonds, Nordpol, Kumulus, Sensoa) • Rectal microbicides advocacy (NFI, HIV Denmark?) • Positive Women Working Group • Comprehensive responses at UNGASS and IEPFPFD, WAD etc - all • Working Groups on target populations • NSWP collaboration (GCM) • EATG collaboration (GCM)

More Related